Clinical Policy: Indications for Reperfusion Therapy in Emergency Department Patients with Suspected Acute Myocardial Infarction

Annals of Emergency Medicine

Volumn 48, Issue 4, 2006, Pages 358-383

  Fesmire, Francis M ^a   Brady, William J ^a   Hahn, Sigrid ^a   Decker, Wyatt W ^a   Diercks, Deborah B ^a   Ghaemmaghami, Chris A ^a   Nazarian, Devorah ^a   Jagoda, Andy S ^a  

^a The American College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; EMERGENCY WARD; HEALTH CARE POLICY; HUMAN; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDLINE; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN; PRIORITY JOURNAL; REVIEW;

ACUTE DISEASE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BUNDLE-BRANCH BLOCK; CASE MANAGEMENT; ELECTROCARDIOGRAPHY; EMERGENCIES; EMERGENCY MEDICAL SERVICES; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; HEALTH POLICY; HUMANS; META-ANALYSIS; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PATIENT TRANSFER; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS;

EID: 33748758425     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2006.07.006     Document Type: Review

References (86)

1. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients with AMI). Circulation 110 (2004) 1-49
2. American College of Emergency Physicians. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected acute myocardial infarction or unstable angina. Ann Emerg Med 35 (2000) 521-544
3. Schriger D.L., Cantrill S.V., and Greene C.S. The origins, benefits, harms, and implications of emergency medicine clinical policies. Ann Emerg Med 22 (1993) 597-602
4. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1 (1986) 397-402
5. Intravenous Streptokinase in Acute Myocardial Infarction (ISAM) Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity, and infarct size at 21 days. N Engl J Med 314 (1986) 1465-1471
6. APSAC Intervention Mortality Study (AIMS) Trial Study Group. Effects of intravenous APSAC on mortality after AMI: preliminary report of a placebo-controlled clinical trial. Lancet 1 (1988) 545-549
7. Second International Study of Infarct Survival (ISIS-2) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2 (1988) 349-360
8. Wilcox R.G., von der Lippe G., Olsson C.G., et al., Anglo-Scandinavian Study of Early Thrombolysis (ASSET) Study Group. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Lancet 2 (1988) 525-530
9. Rossi P., Bolognese L., and Urochinasi per via Sistemica nell' Infarto Miocardico (USIM) Collaborative Group. Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction. Am J Cardiol 68 (1991) 585-592
10. Third International Study of Infarct Survival (ISIS-3) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 339 (1992) 753-770
11. Estudio Multicentrico Estreptoquinasa Republicas de America del Sur (EMERAS) Collaborative Group. Randomized trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 342 (1993) 767-772
12. LATE Study Group. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 342 (1993) 759-766
13. Langer A., Goodman S.G., Topol E.J., et al. Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction (LATE Study Investigators). J Am Coll Cardiol 27 (1996) 1327-1332
14. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1,000 patients. Lancet 343 (1994) 311-322
15. Zalenski R.J., Cooke D., Rydman R., et al. Assessing the diagnostic value of an ECG containing leads V4R, V8, and V9: The 15-lead ECG. Ann Emerg Med 22 (1993) 786-793
16. Zalenski R.J., Rydman R.J., Sloan E.P., et al. Value of posterior and right ventricular leads in comparison to the standard 12-lead electrocardiogram in evaluation of ST-segment elevation in suspected acute myocardial infarction. Am J Cardiol 79 (1997) 1579-1585
17. Bates E.R., Clemmensen P.M., Califf R.M., et al., The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Precordial ST-segment depression predicts a worse prognosis in inferior infarction despite reperfusion therapy. J Am Coll Cardiol 16 (1990) 1538-1544
18. Willems J.L., Willems R.J., Willems G.M., et al., European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator. Significance of initial ST-segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. Circulation 82 (1990) 1147-1158
19. Wong C.K., Freedman S.B., Bautovich G., et al. Mechanism and significance of precordial ST-segment depression during inferior wall acute myocardial infarction associated with severe narrowing of the dominant right coronary artery. Am J Cardiol 71 (1993) 1025-1030
20. Zehender M., Kasper W., Kauder E., et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 328 (1993) 981-988
21. Zehender M., Kasper W., Kauder E., et al. Eligibility for and benefit of thrombolytic therapy in inferior myocardial infarction: focus on the prognostic importance of right ventricular infarction. J Am Coll Cardiol 24 (1994) 362-369
22. Edmunds J.J., Gibbons R.J., Bresnahan J.F., et al. Significance of anterior ST depression in inferior wall acute myocardial infarction. Am J Cardiol 73 (1994) 143-148
23. Birnbaum Y., Herz I., Sclarovsky S., et al. Prognostic significance of precordial ST-segment depression on admission electrocardiogram in patients with inferior wall myocardial infarction. J Am Coll Cardiol 28 (1996) 313-318
24. Peterson E.D., Hathaway W.R., Zabel K.M., et al. Prognostic significance of precordial ST-segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients. J Am Coll Cardiol 28 (1996) 305-312
25. Schroder K., Wegscheider K., Neuhaus K.L., et al. Significance of initial ST-segment changes for thrombolytic treatment in first inferior myocardial infarction. Heart 77 (1997) 506-511
26. Otto L.A., and Aufderheide T.P. Evaluation of ST-segment elevation criteria for the prehospital electrocardiographic diagnosis of acute myocardial infarction. Ann Emerg Med 23 (1994) 17-24
27. Brady W.J., Perron A.D., Syverud S.A., et al. Reciprocal ST-segment depression: impact on the electrocardiographic diagnosis of ST-segment elevation acute myocardial infarction. Am J Emerg Med 20 (2002) 35-38
28. Aufderheide T.P., and Brady W.J. Electrocardiography in the patient with myocardial ischemia or infarction. Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction. In: Gibler W.B., and Aufderheide T.P. (Eds). Emergency Cardiac Care (1994), Mosby-Year Book, St. Louis, MO
29. Brady W.J., Syverud S.A., Beagle C., et al. Electrocardiographic ST-segment elevation: the diagnosis of acute myocardial infarction by morphologic analysis of the ST-segment. Acad Emerg Med 8 (2001) 961-967
30. Brady W.J., Perron A.D., Martin M.L., et al. Cause of ST segment abnormality in ED chest pain patients. Am J Emerg Med 19 (2001) 25-28
31. Pollack M., Thomason G., Williams M., et al. Emergency department diagnosis of acute posterior-wall myocardial infarction using left posterior chest leads. Acad Emerg Med 34 (1997) 399
32. O'Keefe Jr. J.H., Sayed-Taha K., Gibson W., et al. Do patients with left circumflex coronary artery-related acute myocardial infarction without ST-segment elevation benefit from reperfusion therapy?. Am J Cardiol 75 (1995) 718-720
33. Boden W.E., Kleiger R.E., Gibson R.S., et al. Electrocardiographic evolution of posterior acute myocardial infarction: importance of early precordial ST-segment depression. Am J Cardiol 59 (1987) 782-787
34. Braunwald E., and Cannon C.P. Non-Q wave and ST-segment depression myocardial infarction: is there a role for thrombolytic therapy. J Am Coll Cardiol 32 (1996) 1333-1334
35. Dubois C., Pierard L.A., Smeets J.P., et al. Short- and long-term prognostic importance of complete bundle-branch block complicating AMI. Clin Cardiol 11 (1988) 292-296
36. Ricou F., Nicod P., Gilpin E., et al. Influence of right bundle branch block on short- and long-term survival after acute anterior myocardial infarction. J Am Coll Cardiol 17 (1991) 858-863
37. Newby K.H., Pisano E., Krucoff M.W., et al. Incidence and clinical relevance of the occurrence of bundle-branch block in patients treated with thrombolytic therapy. Circulation 94 (1996) 2424-2428
38. Moreno A.M., Alberola A.G., Tomas J.G., et al. Incidence and prognostic significance of right bundle branch block in patients with acute myocardial infarction receiving thrombolytic therapy. Int J Cardiol 61 (1997) 135-141
39. Melgarejo-Moreno A., Galcera-Tomas J., Garcia-Alberola A., et al. Incidence, clinical characteristics, and prognostic significance of right bundle-branch block in acute myocardial infarction: a study in the thrombolytic era. Circulation 96 (1997) 1139-1144
40. Sgarbossa E.B., Pinski S.L., Topol E.J., et al., GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. J Am Coll Cardiol 31 (1998) 105-110
41. Gunnarsson G., Eriksson P., and Dellborg M. Bundle branch block and acute myocardial infarction. Treatment and outcome. Scand Cardiovasc J 34 (2000) 575-579
42. Brilakis E.S., Wright R.S., Kopecky S.L., et al. Bundle branch block as a predictor of long-term survival after acute myocardial infarction. Am J Cardiol 88 (2001) 205-209
43. Melgarejo-Moreno A., Galcera-Tomas J., and Garcia-Alberola A. Prognostic significance of bundle-branch block in acute myocardial infarction: the importance of location and time of appearance. Clin Cardiol 24 (2001) 371-376
44. Go A.S., Barron H.V., Rundle A.C., et al., National Registry of Myocardial Infarction 2 Investigators. Bundle-branch block and in-hospital mortality in acute myocardial infarction. Ann Intern Med 129 (1998) 690-697
45. Ryan T.J., Antman E.M., Brooks N.H., et al. A report of the ACC/AHA TF on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Col Cardiol 34 (1999) 890-911
46. Lee T.H., Cook E.F., Weisberg M., et al. Acute chest pain in the emergency room. Identification and examination of low-risk patients. Arch Intern Med 145 (1985) 65-69
47. Uretsky B.F., Farquhar D.S., Berezin A.F., et al. Symptomatic myocardial infarction without chest pain: prevalence and clinical course. Am J Cardiol 40 (1977) 498-503
48. Murata G.H. Evaluating chest pain in the emergency department. West J Med 159 (1993) 61-68
49. Fesmire F.M., Percy R.F., Wears R.L., et al. Initial ECG in Q wave and non-Q wave myocardial infarction. Ann Emerg Med 18 (1989) 741-746
50. Sgarbossa E.B., Pinski S.L., Barbagelata A., et al., GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. N Engl J Med 334 (1996) 481-487
51. Wackers F.J. The diagnosis of myocardial infarction in the presence of left bundle branch block. Cardiol Clin 5 (1987) 393-401
52. Hands M.E., Cook E.F., Stone P.H., et al. Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block. Am Heart J 116 (1988) 23-31
53. Fesmire F.M. ECG diagnosis of acute myocardial infarction in the presence of left bundle-branch block in patients undergoing continuous ECG monitoring. Ann Emerg Med 26 (1995) 69-82
54. Brady Jr. W.J., and Aufderheide T.P. Left bundle branch block pattern complicating the electrocardiographic evaluation of acute myocardial infarction. Acad Emerg Med 4 (1997) 56-62
55. Shlipak M.G., Lyons W.L., Go A.S., et al. Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial infarction?. JAMA 281 (1999) 714-719
56. Li S.F., Walden P.L., Marcilla O., et al. Electrocardiographic diagnosis of acute myocardial infarction in patients with left bundle branch block. Ann Emerg Med 36 (2000) 561-565
57. Edhouse J.A., Sakr M., Angus J., et al. Suspected myocardial infarction and left bundle branch block: electrocardiographic indicators of acute ischaemia. J Accid Emerg Med 16 (1999) 331-335
58. Sgarbossa E.B., Pinski S.L., Gates K.B., et al., GUSTO-I investigators. Early electrocardiographic diagnosis of acute myocardial infarction in the presence of ventricular paced rhythm. Am J Cardiol 77 (1996) 423-424
59. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
60. Rogers W.J., Dean L.S., Moore P.B., et al., Alabama Registry of Myocardial Ischemia Investigators. Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction. Am J Cardiol 74 (1994) 111-118
61. Tiefenbrunn A.J., Chandra N.C., French W.J., et al. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 31 (1998) 1240-1245
62. Rogers W.J., Canto J.G., Barron H.V., et al., Investigators in the National Registry of Myocardial Infarction. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. J Am Coll Cardiol 35 (2000) 371-379
63. Goldberg R.J., Mooradd M., Gurwitz J.H., et al. Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The Second National Registry of Myocardial Infarction). Am J Cardiol 82 (1998) 259-264
64. Rawles J.M. Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 30 (1997) 1181-1186
65. Boersma E., Maas A.C., Deckers J.W., et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 348 (1996) 771-775
66. Terkelsen C.J., Lassen J.F., Norgaard B.L., et al. Are we underestimating the full potential of early thrombolytic treatment in patients with acute myocardial infarction?. Heart 89 (2003) 483-484
67. Cannon C.P., Gibson C.M., Lambrew C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000) 2941-2947
68. Berger P.B., Ellis S.G., Holmes Jr. D.R., et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation 100 (1999) 14-20
69. Juliard J.M., Feldman L.J., Golmard J.L., et al. Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis in Myocardial Infarction (TIMI) time. Am J Cardiol 91 (2003) 1401-1405
70. De Luca G., Suryapranata H., Zijlstra F., et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 42 (2003) 991-997
71. Zijlstra F., Patel A., Jones C., et al. Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 23 (2002) 550-557
72. De Luca G., Suryapranata H., Ottervanger J.P., et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109 (2004) 1223-1225
73. Antoniucci D., Valenti R., Migliorini A., et al. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 89 (2002) 1248-1252
74. Brodie B.R., Stuckey T.D., Muncy D.B., et al. Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary PCI. Am Heart J 145 (2003) 708-715
75. Kent D.M., Lau J., and Selker H.P. Balancing the benefits of primary angioplasty against the benefits of thrombolytic therapy for acute myocardial infarction: the importance of timing. Eff Clin Pract 4 (2001) 214-220
76. Nallamothu B.K., and Bates E.R. PCI versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?. Am J Cardiol 92 (2003) 824-826
77. Betriu A., and Masotti M. Comparison of mortality rates in acute myocardial infarction treated by PCI versus fibrinolysis. Am J Cardiol 95 (2005) 100-101
78. Grines C., Patel A., Zijlstra F., et al., PCAT Collaborators. Percutaneous transluminal coronary angioplasty. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. Am Heart J 145 (2003) 47-57
79. Bonnefoy E., Lapostolle F., Leizorovcz A., et al. Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) Study Group. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 360 (2002) 825-829
80. Steg P.G., Bonnefoy E., Chabaud S., et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty. Data from the CAPTIM randomized clinical trial. Circulation 108 (2003) 2851-2856
81. Grines C.L., Westerhausen Jr. D.R., Grines L.L., et al., The Air Primary Angioplasty in Myocardial Infarction Study Group. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction. J Am Coll Cardiol 39 (2002) 1713-1719
82. Dalby M., Bouzamondo A., Lechat P., et al. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 108 (2003) 1809-1814
83. Vermeer F., Oude Ophuis A.J., vd Berg E.J., et al. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart 82 (1999) 426-431
84. Widimsky P., Groch L., Zelizko M., et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE Study. Eur Heart J 21 (2000) 823-831
85. Widimsky P., Budesinsky T., Vorac D., et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2. Eur Heart J 24 (2003) 94-104
86. Andersen H.R., Nielsen T.T., Rasmussen K., et al., DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349 (2003) 733-742